FORTIS902.00

Fortis Healthcare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHMEDANTAAUROPHARMALUPINALKEMLAURUSLABSMANKINDMcap ₹68,097 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt858.32,475.12,872.72,872.7
Net Debt623.02,335.42,448.42,448.4
Total Debt/Equity0.100.270.280.28
Net Debt/Equity0.070.250.240.24
Total Debt/EBITDA0.681.561.381.38
Net Debt/EBITDA0.491.471.171.15
Interest Coverage (EBIT/Interest)7.066.525.205.20
Total Debt/Total Capital %9.1221.2622.0322.03
As Filed — company-reported covenants
Debt/Equity (as filed)0.270.340.31
Debt Service Coverage (as filed)3.881.831.06
Interest Service Coverage (as filed)9.046.846.91
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.